Mani Inc
TSE:7730
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (5.6), the stock would be worth ¥2 553.66 (50% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 3.7 | ¥1 697 |
0%
|
| 3-Year Average | 5.6 | ¥2 553.66 |
+50%
|
| 5-Year Average | 6.6 | ¥3 042.25 |
+79%
|
| Industry Average | 1.7 | ¥782.48 |
-54%
|
| Country Average | 1.1 | ¥510.93 |
-70%
|
Forward EV/S
Today’s price vs future revenue
| Today's Enterprise Value | Revenue | Forward EV/S | ||
|---|---|---|---|---|
|
¥160.9B
|
/ |
Mar 2026
¥39.1B
|
= |
|
|
¥160.9B
|
/ |
Aug 2026
¥33.6B
|
= |
|
|
¥160.9B
|
/ |
Aug 2027
¥36.5B
|
= |
|
|
¥160.9B
|
/ |
Aug 2028
¥39.6B
|
= |
|
Forward EV/S shows whether today’s EV/S still looks high or low once future revenue are taken into account.
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Mani Inc
TSE:7730
|
167.2B JPY | 3.7 | 22.3 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.9T JPY | 10.2 | 39.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
58.1B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 3.8 | 37.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
91B DKK | 4 | 23.2 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 2.9 | 30.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.2B GBP | 2.9 | 32.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
905.8B JPY | 6.6 | 51.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 2 | -15.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.2T KRW | 97.6 | -37.2 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
37.7B CNY | 3.3 | 22.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0.7 |
| Median | 1.1 |
| 70th Percentile | 2 |
| Max | 12 107 466 |
Other Multiples
Mani Inc
Glance View
In the dynamic landscape of modern manufacturing, Mani Inc. emerges as a pivotal player, weaving together innovation and tradition in the realm of precision tools. Founded in the late 20th century, the company quickly distinguished itself by specializing in the design and production of high-quality dental and medical instruments. At its core, Mani Inc. thrives on its commitment to quality and reliability, underpinning its operations with cutting-edge technology and meticulous craftsmanship. Boasting a global presence, the company navigates a complex supply chain and adheres to stringent regulatory standards, ensuring its tools meet the diverse needs of practitioners around the world. Mani Inc. engages directly with dental professionals and healthcare institutions, building lasting relationships that are strengthened by the consistent performance and longevity of its products. Economically, Mani Inc. capitalizes on its expansive distribution network and brand loyalty to generate revenue, with a business model that focuses on both direct sales and partnerships with distributors. This approach allows the company not only to reach a wide array of international markets but also to tailor its offerings to specific regional demands. Its commitment to research and development propels innovation that further solidifies its market position, helping to safeguard against the fluctuations that often characterize the medical tools segment. By investing significantly in R&D, Mani Inc. ensures its product lineup remains at the forefront of technology and efficiency, thereby reinforcing its competitive edge in an industry where precision is paramount.
